Copper-based Microbiome Modulation for Diverse Health Applications
Legal Citation
Summary of the Inventive Concept
A novel approach to leveraging copper's antimicrobial properties to develop innovative solutions for various health issues, including respiratory diseases, cognitive function, skin diseases, eye diseases, and athletic performance.
Background and Problem Solved
The original patent disclosed a method for reducing HPV incidence and prevalence by modifying the cervical microbiome. However, this technology has untapped potential for addressing other significant health concerns. The new inventive concept expands on this core technology to tackle unmet needs in diverse fields, providing a comprehensive solution for various diseases and health issues.
Detailed Description of the Inventive Concept
The new inventive concept encompasses a range of copper-based devices and systems designed to modulate the microbiome in different parts of the body. For instance, a respiratory device with a surface area between 100 mm2 to 200 mm2 can be used to reduce the incidence of respiratory diseases by modifying the respiratory microbiome. Similarly, a wearable device with a surface area between 50 mm2 to 100 mm2 can enhance cognitive function by increasing local immunity in the brain. Other embodiments include skin patches, eye masks, and athletic performance-enhancing devices, all leveraging copper's antimicrobial properties to address specific health concerns.
Novelty and Inventive Step
The new claims introduce a paradigm shift by applying the core technology to entirely new fields and use cases, demonstrating a non-obvious expansion of the original patent's concepts. The inventive step lies in recognizing the broader potential of copper-based microbiome modulation and adapting it to address diverse health issues.
Alternative Embodiments and Variations
Alternative embodiments could include the use of different materials or geometries for the devices, as well as varying surface areas or configurations to optimize performance. Additionally, the concept could be extended to other health applications, such as wound healing or gastrointestinal health, further broadening its scope.
Potential Commercial Applications and Market
The copper-based microbiome modulation technology has vast commercial potential, with applications in various industries, including healthcare, wellness, sports, and cosmetics. The target market includes individuals seeking preventative measures or treatments for respiratory diseases, cognitive function, skin diseases, eye diseases, and athletic performance enhancement, as well as companies looking to integrate this technology into their products or services.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0039 |
| A | A61 | A61F6/144 |
| A | A61 | A61K33/34 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device design and microbiome modulation technologies, specifically focusing on copper-based devices for health interventions, with expertise in surface area optimization, material selection, and localized biological interactions
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced knowledge of materials science, microbiome interactions, and device design principles, capable of understanding antimicrobial properties and translating therapeutic concepts across different physiological systems
Obviousness Rationale
The PTD represents a predictable extension of the source patent's core technological concept of using copper-based devices to modulate microbiomes and enhance local immunity. A PHOSITA would recognize the fundamental principle of copper's antimicrobial properties as universally applicable across different bodily systems, making the translation of the original cervical device concept to respiratory, cognitive, skin, and muscular applications a logical and obvious design progression.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,675 |
|---|---|
| Title | Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections |